Approximately half of patients admitted to hospitals present changes in coagulation parameters, including elevated D-dimer, prolonged prothrombin time, low fibrinogen levels, and/or thrombocytopenia, which are associated with elevated risk for episodes of thrombosis than hemorrhagic (Gomez-Mesa et al., 2021). The gene discussed is F2; the disease is Thrombocytopenia.